nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—HTR3A—schizophrenia	0.737	0.782	CbGaD
Dolasetron—CYP2D6—schizophrenia	0.205	0.218	CbGaD
Dolasetron—CYP2C9—urine—schizophrenia	0.00263	0.122	CbGeAlD
Dolasetron—Hyoscyamine—CHRM1—schizophrenia	0.00221	0.442	CrCbGaD
Dolasetron—CYP3A4—urine—schizophrenia	0.00201	0.0934	CbGeAlD
Dolasetron—CYP2D6—urine—schizophrenia	0.00197	0.0919	CbGeAlD
Dolasetron—Atropine—CHRM1—schizophrenia	0.00188	0.376	CrCbGaD
Dolasetron—HTR3A—forebrain—schizophrenia	0.00154	0.0715	CbGeAlD
Dolasetron—HTR3A—telencephalon—schizophrenia	0.00141	0.0657	CbGeAlD
Dolasetron—CYP2C9—blood plasma—schizophrenia	0.00137	0.0639	CbGeAlD
Dolasetron—CYP3A4—blood plasma—schizophrenia	0.00105	0.0487	CbGeAlD
Dolasetron—CYP2D6—blood plasma—schizophrenia	0.00103	0.048	CbGeAlD
Dolasetron—HTR3A—blood—schizophrenia	0.00103	0.0478	CbGeAlD
Dolasetron—Atropine—CYP1A2—schizophrenia	0.000909	0.182	CrCbGaD
Dolasetron—HTR3A—nervous system—schizophrenia	0.000834	0.0388	CbGeAlD
Dolasetron—HTR3A—central nervous system—schizophrenia	0.000803	0.0374	CbGeAlD
Dolasetron—HTR3A—brain—schizophrenia	0.000637	0.0297	CbGeAlD
Dolasetron—CYP2D6—forebrain—schizophrenia	0.000564	0.0263	CbGeAlD
Dolasetron—CYP2D6—telencephalon—schizophrenia	0.000519	0.0242	CbGeAlD
Dolasetron—CYP2C9—blood—schizophrenia	0.000503	0.0234	CbGeAlD
Dolasetron—CYP2C9—endocrine gland—schizophrenia	0.000436	0.0203	CbGeAlD
Dolasetron—CYP3A4—blood—schizophrenia	0.000384	0.0179	CbGeAlD
Dolasetron—CYP2D6—blood—schizophrenia	0.000377	0.0176	CbGeAlD
Dolasetron—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—schizophrenia	0.000341	0.0108	CbGpPWpGaD
Dolasetron—CYP3A4—endocrine gland—schizophrenia	0.000333	0.0155	CbGeAlD
Dolasetron—CYP3A4—Aflatoxin B1 metabolism—GSTM1—schizophrenia	0.000331	0.0105	CbGpPWpGaD
Dolasetron—CYP2D6—endocrine gland—schizophrenia	0.000327	0.0152	CbGeAlD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.000325	0.0103	CbGpPWpGaD
Dolasetron—CYP2C9—Xenobiotics—CYP2D6—schizophrenia	0.000313	0.00993	CbGpPWpGaD
Dolasetron—CYP3A4—nervous system—schizophrenia	0.000311	0.0145	CbGeAlD
Dolasetron—CYP3A4—Codeine and Morphine Metabolism—ABCB1—schizophrenia	0.000307	0.00973	CbGpPWpGaD
Dolasetron—CYP2D6—nervous system—schizophrenia	0.000306	0.0143	CbGeAlD
Dolasetron—CYP2D6—Melatonin metabolism and effects—CLOCK—schizophrenia	0.000301	0.00955	CbGpPWpGaD
Dolasetron—CYP2C9—Tamoxifen metabolism—CYP2D6—schizophrenia	0.000301	0.00955	CbGpPWpGaD
Dolasetron—CYP3A4—central nervous system—schizophrenia	0.0003	0.014	CbGeAlD
Dolasetron—HTR3A—Ion channel transport—ATP2A2—schizophrenia	0.000296	0.00941	CbGpPWpGaD
Dolasetron—CYP2D6—central nervous system—schizophrenia	0.000295	0.0137	CbGeAlD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.000295	0.00936	CbGpPWpGaD
Dolasetron—CYP2D6—cerebellum—schizophrenia	0.000288	0.0134	CbGeAlD
Dolasetron—CYP2D6—Xenobiotics—CYP1A2—schizophrenia	0.000285	0.00906	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.000284	0.00901	CbGpPWpGaD
Dolasetron—CYP2C9—Xenobiotics—CYP1A2—schizophrenia	0.000283	0.00898	CbGpPWpGaD
Dolasetron—CYP2D6—Tamoxifen metabolism—CYP1A2—schizophrenia	0.000274	0.00871	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.000274	0.0087	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.000274	0.0087	CbGpPWpGaD
Dolasetron—CYP2C9—Tamoxifen metabolism—CYP1A2—schizophrenia	0.000272	0.00864	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.000266	0.00846	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—FXYD6—schizophrenia	0.000266	0.00844	CbGpPWpGaD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—schizophrenia	0.000247	0.00783	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—TH—schizophrenia	0.000244	0.00775	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.000243	0.0077	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.000241	0.00764	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.000239	0.0076	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.000237	0.00754	CbGpPWpGaD
Dolasetron—CYP2D6—brain—schizophrenia	0.000234	0.0109	CbGeAlD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—schizophrenia	0.000223	0.00708	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—CYP1A2—schizophrenia	0.000212	0.00673	CbGpPWpGaD
Dolasetron—CYP3A4—Xenobiotics—CYP2D6—schizophrenia	0.000206	0.00655	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.000206	0.00654	CbGpPWpGaD
Dolasetron—CYP3A4—Estrogen metabolism—CYP1A2—schizophrenia	0.000203	0.00644	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.000199	0.00631	CbGpPWpGaD
Dolasetron—CYP3A4—Tamoxifen metabolism—CYP2D6—schizophrenia	0.000198	0.0063	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.000197	0.00624	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.000195	0.00619	CbGpPWpGaD
Dolasetron—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—schizophrenia	0.000194	0.00617	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL10—schizophrenia	0.00019	0.00603	CbGpPWpGaD
Dolasetron—CYP3A4—Xenobiotics—CYP1A2—schizophrenia	0.000187	0.00592	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—schizophrenia	0.000185	0.00587	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.000185	0.00586	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC1A1—schizophrenia	0.00018	0.0057	CbGpPWpGaD
Dolasetron—CYP3A4—Tamoxifen metabolism—CYP1A2—schizophrenia	0.000179	0.0057	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.000179	0.00567	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—MAOA—schizophrenia	0.000176	0.0056	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—TPH1—schizophrenia	0.000175	0.00555	CbGpPWpGaD
Dolasetron—CYP3A4—Estrogen metabolism—COMT—schizophrenia	0.00017	0.0054	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.000168	0.00534	CbGpPWpGaD
Dolasetron—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—schizophrenia	0.000168	0.00533	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC17A7—schizophrenia	0.000164	0.00521	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.000159	0.00504	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.000157	0.00497	CbGpPWpGaD
Dolasetron—CYP3A4—Estrogen metabolism—GSTM1—schizophrenia	0.000156	0.00494	CbGpPWpGaD
Dolasetron—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—schizophrenia	0.000153	0.00487	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—NDST3—schizophrenia	0.00015	0.00477	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—NDST3—schizophrenia	0.000149	0.00473	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	0.000146	0.00464	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—GABRB2—schizophrenia	0.000146	0.00462	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—CYP1A2—schizophrenia	0.000136	0.00432	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—APOE—schizophrenia	0.000134	0.00424	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.00013	0.00412	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.000129	0.00408	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.000128	0.00407	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC18A2—schizophrenia	0.000126	0.00399	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—schizophrenia	0.000122	0.00387	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.000118	0.00376	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.000117	0.00373	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.000117	0.00371	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.000116	0.00368	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—GSK3B—schizophrenia	0.000116	0.00368	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC6A1—schizophrenia	0.000116	0.00367	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.000105	0.00334	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP26B1—schizophrenia	0.000104	0.00332	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—PLA2G4A—schizophrenia	0.000104	0.00331	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP26B1—schizophrenia	0.000104	0.00329	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ATP2A2—schizophrenia	0.000103	0.00327	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP26B1—schizophrenia	0.000103	0.00327	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP26B1—schizophrenia	0.000102	0.00324	CbGpPWpGaD
Dolasetron—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—schizophrenia	0.000101	0.00321	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL1B—schizophrenia	9.96e-05	0.00316	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—NDST3—schizophrenia	9.83e-05	0.00312	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	9.63e-05	0.00306	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	9.61e-05	0.00305	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—CYP1A2—schizophrenia	9.58e-05	0.00304	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	9.52e-05	0.00302	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—GCLM—schizophrenia	9.31e-05	0.00296	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GCLM—schizophrenia	9.23e-05	0.00293	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—EP300—schizophrenia	8.9e-05	0.00283	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	8.57e-05	0.00272	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	8.45e-05	0.00268	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—schizophrenia	8.25e-05	0.00262	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	7.99e-05	0.00254	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	7.92e-05	0.00252	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	7.75e-05	0.00246	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	7.65e-05	0.00243	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—TNF—schizophrenia	7.23e-05	0.00229	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	6.94e-05	0.0022	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP26B1—schizophrenia	6.83e-05	0.00217	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP26B1—schizophrenia	6.74e-05	0.00214	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCB1—schizophrenia	6.61e-05	0.0021	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	6.28e-05	0.00199	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GCLM—schizophrenia	6.09e-05	0.00193	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP2D6—schizophrenia	5.59e-05	0.00178	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP2D6—schizophrenia	5.52e-05	0.00175	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	5.5e-05	0.00175	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	5.5e-05	0.00175	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	5.23e-05	0.00166	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—APOA1—schizophrenia	5.22e-05	0.00166	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP1A2—schizophrenia	5.1e-05	0.00162	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP1A2—schizophrenia	5.06e-05	0.00161	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP1A2—schizophrenia	5.03e-05	0.0016	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP1A2—schizophrenia	4.99e-05	0.00158	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	4.4e-05	0.0014	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—COMT—schizophrenia	4.28e-05	0.00136	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—GSTP1—schizophrenia	4.26e-05	0.00135	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—MAOA—schizophrenia	4.25e-05	0.00135	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—COMT—schizophrenia	4.24e-05	0.00135	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GSTP1—schizophrenia	4.22e-05	0.00134	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—COMT—schizophrenia	4.22e-05	0.00134	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—MAOA—schizophrenia	4.21e-05	0.00134	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—GSTP1—schizophrenia	4.2e-05	0.00133	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—COMT—schizophrenia	4.18e-05	0.00133	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—GSTP1—schizophrenia	4.16e-05	0.00132	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—GSTM1—schizophrenia	3.91e-05	0.00124	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GSTM1—schizophrenia	3.88e-05	0.00123	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—GSTM1—schizophrenia	3.86e-05	0.00122	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—GSTM1—schizophrenia	3.82e-05	0.00121	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	3.69e-05	0.00117	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PRODH—schizophrenia	3.66e-05	0.00116	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	3.64e-05	0.00116	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PRODH—schizophrenia	3.63e-05	0.00115	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	3.34e-05	0.00106	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	3.33e-05	0.00106	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	3.29e-05	0.00104	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MPC2—schizophrenia	2.98e-05	0.000947	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MPC2—schizophrenia	2.96e-05	0.000939	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—COMT—schizophrenia	2.8e-05	0.000888	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GSTP1—schizophrenia	2.78e-05	0.000883	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—MAOA—schizophrenia	2.78e-05	0.000881	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLCH2—schizophrenia	2.77e-05	0.00088	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	2.76e-05	0.000875	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	2.76e-05	0.000875	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLCH2—schizophrenia	2.75e-05	0.000873	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	2.74e-05	0.000871	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NDST3—schizophrenia	2.61e-05	0.000828	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NDST3—schizophrenia	2.58e-05	0.000821	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GSTM1—schizophrenia	2.56e-05	0.000812	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	2.52e-05	0.000801	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ACSL6—schizophrenia	2.47e-05	0.000785	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC27A5—schizophrenia	2.47e-05	0.000785	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC27A5—schizophrenia	2.45e-05	0.000778	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ACSL6—schizophrenia	2.45e-05	0.000778	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	2.39e-05	0.00076	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PRODH—schizophrenia	2.39e-05	0.000759	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—DAO—schizophrenia	2.36e-05	0.000749	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—DAO—schizophrenia	2.34e-05	0.000742	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PNP—schizophrenia	2.26e-05	0.000718	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PNP—schizophrenia	2.24e-05	0.000711	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NDUFV2—schizophrenia	2.1e-05	0.000667	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NDUFV2—schizophrenia	2.08e-05	0.000661	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIP4K2A—schizophrenia	1.98e-05	0.000627	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIP4K2A—schizophrenia	1.96e-05	0.000622	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MPC2—schizophrenia	1.95e-05	0.000619	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	1.94e-05	0.000617	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLCH2—schizophrenia	1.81e-05	0.000576	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP26B1—schizophrenia	1.79e-05	0.000567	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP26B1—schizophrenia	1.77e-05	0.000562	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NDST3—schizophrenia	1.7e-05	0.000541	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC27A5—schizophrenia	1.62e-05	0.000513	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ACSL6—schizophrenia	1.62e-05	0.000513	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TPH1—schizophrenia	1.59e-05	0.000506	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GCLM—schizophrenia	1.59e-05	0.000506	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TPH1—schizophrenia	1.58e-05	0.000501	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GCLM—schizophrenia	1.58e-05	0.000501	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—DAO—schizophrenia	1.54e-05	0.000489	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PRKD1—schizophrenia	1.5e-05	0.000475	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.49e-05	0.000473	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PRKD1—schizophrenia	1.48e-05	0.000471	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PNP—schizophrenia	1.48e-05	0.000469	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NDUFV2—schizophrenia	1.37e-05	0.000436	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIP4K2A—schizophrenia	1.29e-05	0.00041	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GAPDH—schizophrenia	1.25e-05	0.000397	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GAPDH—schizophrenia	1.24e-05	0.000393	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CLOCK—schizophrenia	1.24e-05	0.000393	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CLOCK—schizophrenia	1.23e-05	0.00039	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.22e-05	0.000389	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.21e-05	0.000384	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TPH2—schizophrenia	1.21e-05	0.000383	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CACNB2—schizophrenia	1.21e-05	0.000383	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TPH2—schizophrenia	1.2e-05	0.00038	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CACNB2—schizophrenia	1.2e-05	0.00038	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—DPYD—schizophrenia	1.19e-05	0.000377	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—DPYD—schizophrenia	1.18e-05	0.000374	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP26B1—schizophrenia	1.17e-05	0.000371	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CACNA1C—schizophrenia	1.1e-05	0.00035	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CACNA1C—schizophrenia	1.09e-05	0.000347	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3C2A—schizophrenia	1.08e-05	0.000342	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3C2A—schizophrenia	1.07e-05	0.000339	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TPH1—schizophrenia	1.04e-05	0.000331	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GCLM—schizophrenia	1.04e-05	0.000331	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PRKD1—schizophrenia	9.79e-06	0.000311	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SNAP25—schizophrenia	9.65e-06	0.000306	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SNAP25—schizophrenia	9.57e-06	0.000304	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2D6—schizophrenia	9.57e-06	0.000304	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP1A2—schizophrenia	8.73e-06	0.000277	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP1A2—schizophrenia	8.65e-06	0.000275	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TH—schizophrenia	8.6e-06	0.000273	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TH—schizophrenia	8.53e-06	0.000271	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GAPDH—schizophrenia	8.17e-06	0.000259	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CLOCK—schizophrenia	8.1e-06	0.000257	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CACNB2—schizophrenia	7.89e-06	0.000251	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TPH2—schizophrenia	7.89e-06	0.000251	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—DPYD—schizophrenia	7.76e-06	0.000246	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—COMT—schizophrenia	7.31e-06	0.000232	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTP1—schizophrenia	7.28e-06	0.000231	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MAOA—schizophrenia	7.26e-06	0.000231	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—COMT—schizophrenia	7.25e-06	0.00023	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CACNA1C—schizophrenia	7.22e-06	0.000229	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTP1—schizophrenia	7.22e-06	0.000229	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MAOA—schizophrenia	7.2e-06	0.000229	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3C2A—schizophrenia	7.03e-06	0.000223	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	6.98e-06	0.000222	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCB1—schizophrenia	6.89e-06	0.000219	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCB1—schizophrenia	6.83e-06	0.000217	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLA2G4A—schizophrenia	6.69e-06	0.000212	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTM1—schizophrenia	6.69e-06	0.000212	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLA2G4A—schizophrenia	6.63e-06	0.000211	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTM1—schizophrenia	6.63e-06	0.000211	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2D6—schizophrenia	6.31e-06	0.0002	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SNAP25—schizophrenia	6.31e-06	0.0002	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MTHFR—schizophrenia	5.91e-06	0.000188	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MTHFR—schizophrenia	5.86e-06	0.000186	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP1A2—schizophrenia	5.71e-06	0.000181	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TH—schizophrenia	5.62e-06	0.000179	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOE—schizophrenia	5.5e-06	0.000175	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOE—schizophrenia	5.46e-06	0.000173	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA1—schizophrenia	5.44e-06	0.000173	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA1—schizophrenia	5.39e-06	0.000171	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—COMT—schizophrenia	4.78e-06	0.000152	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTP1—schizophrenia	4.76e-06	0.000151	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MAOA—schizophrenia	4.75e-06	0.000151	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCB1—schizophrenia	4.5e-06	0.000143	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTM1—schizophrenia	4.37e-06	0.000139	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLA2G4A—schizophrenia	4.37e-06	0.000139	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MTHFR—schizophrenia	3.86e-06	0.000123	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOE—schizophrenia	3.6e-06	0.000114	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA1—schizophrenia	3.56e-06	0.000113	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—EP300—schizophrenia	3.14e-06	9.96e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—EP300—schizophrenia	3.11e-06	9.87e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—EP300—schizophrenia	2.05e-06	6.51e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKT1—schizophrenia	1.9e-06	6.02e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKT1—schizophrenia	1.88e-06	5.96e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKT1—schizophrenia	1.24e-06	3.93e-05	CbGpPWpGaD
